According to the international journal 'Science' on the 16th, global pharmaceutical companies are racing to develop oral GLP-1 drugs
In the central nervous system, they act on appetite-regulating centers in the hypothalamus, reducing hunger and increasing satiety signals
Diabetes 60(12):31033109 Yanagimachi T, Fujita Y, Takeda Y et al (2016) Pancreatic glucose-dependent insulinotropic polypeptide (GIP) (130) expression is upregulated in diabetes and PEGylated GIP(130) can suppress the progression of low-dose-STZ-induced hyperglycaemia in mice
86 Storgaard H, Cold F, Gluud LL, Vilsboll T, Knop FK
The outcome of the case, whether it is a settlement or a trial verdict, applies collectively to all class members
Non-12-OH FXR-antagonistic BAs mediates the T3 effect on glucose homeostasis To dissect the contribution of the augmentation of non-12-OH FXR-antagonistic BAs to the improved glucose metabolism after T3 daily injection, MMI mice were fed a diet supplemented with TMCA, the most abundant murine FXR-antagonistic BA, for five days